Geberit AG (0QQ2)
London Exchange · UK · prices in GBP · close of 22 Oct 2026
Key indicators
| Last close | GBP 557.10 |
|---|---|
| 52-week range | 488.10 – 662.20 |
| Return, 1 month / 3 months | +1.4% / +7.9% |
| Return, 1 year / 3 years | −9.2% / +33.7% |
| Trend | Uptrend |
| RSI (14) | 59 |
| Volatility (1 year) | 22.6% |
| Worst drawdown (1 year) | -24.4% |
| Average daily value traded | 7.06M GBP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Geberit AG is a Swiss manufacturer of sanitary products and plumbing systems, based in Rapperswil-Jona. The company makes concealed cisterns, installation frames, flushing systems, ceramic sanitaryware, taps and piping for water supply and drainage. Its customers are mainly plumbing and sanitary installers, wholesalers and building professionals, who fit its products in homes, commercial buildings and public facilities. Geberit supplies these systems across Europe and other markets, combining behind-the-wall installation technology with visible bathroom fittings and piping.
On this site Geberit AG appears as a stock on the London Exchange (UK), code 0QQ2, with prices in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Geberit AG (0QQ2) trades on the London Exchange in UK. It last closed at GBP 557.10 on 22 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 1,249 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 9.2% and over the last three months it rose 7.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 51 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.6% | ||
| From 52-week high | -14.8% | ||
| Momentum | 55 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 7.9% | ||
| 6-month return | 4.5% | ||
| 12-month return, skipping the last month | -10.4% | ||
| Stability (higher is calmer) | 72 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 22.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.4% | ||
| Liquidity | 71 · Strong | Trades actively. | |
| Average daily value traded | 7.06M GBP | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.5% |
|---|---|
| 1 month | +1.4% |
| 3 months | +7.9% |
| 6 months | +4.5% |
| 1 year | −9.2% |
| 3 years | +33.7% |
| 5 years | −22.5% |
Signals
| 50-day / 200-day average | 551.31 / 553.69 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 8.43 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Apr 2026 | GBX 0.1290 |
| 22 Apr 2025 | GBX 0.1280 |
| 19 Apr 2024 | GBX 0.1270 |
| 21 Apr 2023 | GBX 0.1260 |
| 19 Apr 2022 | GBX 0.1250 |
| 16 Apr 2021 | GBX 0.1140 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.